| Steven M Zeldis, MD | |
|
200 Old Country Rd, #278, Mineola, NY 11501-4235 | |
| (516) 877-0977 | |
| (516) 294-6861 |
| Full Name | Steven M Zeldis |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 52 Years |
| Location | 200 Old Country Rd, Mineola, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134107048 | NPI | - | NPPES |
| 00268231 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 129804 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New York University Langone Medical Center | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New York University | 1355232422 | 4431 |
News Archive
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 1, pp. 71-75(5); DOI https://doi.org/10.15212/CVIA.2017.0076, Robert F. Hamburger, DO, MPH, FACC, from the Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, FL, USA and Malcom Randall VA Medical Center, Gainesville, FL, USA considers adult congenital heart disease in the veteran population.
Florida is failing to ensure the dental health needs of its children, according to a report released by the Pew Center on the States.
BioLineRx, a biopharmaceutical development company, today announced that it has signed a worldwide, exclusive license agreement with Ramot at Tel Aviv University Ltd., the technology transfer company of Tel Aviv University, for the development and commercialization of BL-7050, a novel, orally-available treatment for neuropathic and inflammatory pain.
Through serendipity, researchers at the University of Pittsburgh Graduate School of Public Health considerably reduced the toxicity of a potential antibiotic against the most feared drug-resistant bacteria, while also improving its stability in fighting infections.
› Verified 5 days ago
| Entity Name | Steven S Shayani Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972531564 PECOS PAC ID: 5991697880 Enrollment ID: O20040325001716 |
News Archive
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 1, pp. 71-75(5); DOI https://doi.org/10.15212/CVIA.2017.0076, Robert F. Hamburger, DO, MPH, FACC, from the Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, FL, USA and Malcom Randall VA Medical Center, Gainesville, FL, USA considers adult congenital heart disease in the veteran population.
Florida is failing to ensure the dental health needs of its children, according to a report released by the Pew Center on the States.
BioLineRx, a biopharmaceutical development company, today announced that it has signed a worldwide, exclusive license agreement with Ramot at Tel Aviv University Ltd., the technology transfer company of Tel Aviv University, for the development and commercialization of BL-7050, a novel, orally-available treatment for neuropathic and inflammatory pain.
Through serendipity, researchers at the University of Pittsburgh Graduate School of Public Health considerably reduced the toxicity of a potential antibiotic against the most feared drug-resistant bacteria, while also improving its stability in fighting infections.
› Verified 5 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20081202000185 |
News Archive
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 1, pp. 71-75(5); DOI https://doi.org/10.15212/CVIA.2017.0076, Robert F. Hamburger, DO, MPH, FACC, from the Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, FL, USA and Malcom Randall VA Medical Center, Gainesville, FL, USA considers adult congenital heart disease in the veteran population.
Florida is failing to ensure the dental health needs of its children, according to a report released by the Pew Center on the States.
BioLineRx, a biopharmaceutical development company, today announced that it has signed a worldwide, exclusive license agreement with Ramot at Tel Aviv University Ltd., the technology transfer company of Tel Aviv University, for the development and commercialization of BL-7050, a novel, orally-available treatment for neuropathic and inflammatory pain.
Through serendipity, researchers at the University of Pittsburgh Graduate School of Public Health considerably reduced the toxicity of a potential antibiotic against the most feared drug-resistant bacteria, while also improving its stability in fighting infections.
› Verified 5 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 1, pp. 71-75(5); DOI https://doi.org/10.15212/CVIA.2017.0076, Robert F. Hamburger, DO, MPH, FACC, from the Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, FL, USA and Malcom Randall VA Medical Center, Gainesville, FL, USA considers adult congenital heart disease in the veteran population.
Florida is failing to ensure the dental health needs of its children, according to a report released by the Pew Center on the States.
BioLineRx, a biopharmaceutical development company, today announced that it has signed a worldwide, exclusive license agreement with Ramot at Tel Aviv University Ltd., the technology transfer company of Tel Aviv University, for the development and commercialization of BL-7050, a novel, orally-available treatment for neuropathic and inflammatory pain.
Through serendipity, researchers at the University of Pittsburgh Graduate School of Public Health considerably reduced the toxicity of a potential antibiotic against the most feared drug-resistant bacteria, while also improving its stability in fighting infections.
› Verified 5 days ago
| Entity Name | Winthrop Community Medical Affiliates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457873077 PECOS PAC ID: 5698092385 Enrollment ID: O20150317001669 |
News Archive
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 1, pp. 71-75(5); DOI https://doi.org/10.15212/CVIA.2017.0076, Robert F. Hamburger, DO, MPH, FACC, from the Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, FL, USA and Malcom Randall VA Medical Center, Gainesville, FL, USA considers adult congenital heart disease in the veteran population.
Florida is failing to ensure the dental health needs of its children, according to a report released by the Pew Center on the States.
BioLineRx, a biopharmaceutical development company, today announced that it has signed a worldwide, exclusive license agreement with Ramot at Tel Aviv University Ltd., the technology transfer company of Tel Aviv University, for the development and commercialization of BL-7050, a novel, orally-available treatment for neuropathic and inflammatory pain.
Through serendipity, researchers at the University of Pittsburgh Graduate School of Public Health considerably reduced the toxicity of a potential antibiotic against the most feared drug-resistant bacteria, while also improving its stability in fighting infections.
› Verified 5 days ago
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487016507 PECOS PAC ID: 6709174493 Enrollment ID: O20161012002352 |
News Archive
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 1, pp. 71-75(5); DOI https://doi.org/10.15212/CVIA.2017.0076, Robert F. Hamburger, DO, MPH, FACC, from the Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, FL, USA and Malcom Randall VA Medical Center, Gainesville, FL, USA considers adult congenital heart disease in the veteran population.
Florida is failing to ensure the dental health needs of its children, according to a report released by the Pew Center on the States.
BioLineRx, a biopharmaceutical development company, today announced that it has signed a worldwide, exclusive license agreement with Ramot at Tel Aviv University Ltd., the technology transfer company of Tel Aviv University, for the development and commercialization of BL-7050, a novel, orally-available treatment for neuropathic and inflammatory pain.
Through serendipity, researchers at the University of Pittsburgh Graduate School of Public Health considerably reduced the toxicity of a potential antibiotic against the most feared drug-resistant bacteria, while also improving its stability in fighting infections.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven M Zeldis, MD 200 Old Country Rd, #278, Mineola, NY 11501-4235 Ph: (516) 877-0977 | Steven M Zeldis, MD 200 Old Country Rd, #278, Mineola, NY 11501-4235 Ph: (516) 877-0977 |
News Archive
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 1, pp. 71-75(5); DOI https://doi.org/10.15212/CVIA.2017.0076, Robert F. Hamburger, DO, MPH, FACC, from the Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, FL, USA and Malcom Randall VA Medical Center, Gainesville, FL, USA considers adult congenital heart disease in the veteran population.
Florida is failing to ensure the dental health needs of its children, according to a report released by the Pew Center on the States.
BioLineRx, a biopharmaceutical development company, today announced that it has signed a worldwide, exclusive license agreement with Ramot at Tel Aviv University Ltd., the technology transfer company of Tel Aviv University, for the development and commercialization of BL-7050, a novel, orally-available treatment for neuropathic and inflammatory pain.
Through serendipity, researchers at the University of Pittsburgh Graduate School of Public Health considerably reduced the toxicity of a potential antibiotic against the most feared drug-resistant bacteria, while also improving its stability in fighting infections.
› Verified 5 days ago
Dr. Marlene Martins Lobato, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 173 Mineola Blvd, Suite 403, Mineola, NY 11501 Phone: 516-741-8891 Fax: 516-741-8829 | |
Michael Garrison, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 200 Old Country Rd, Suite 450, Mineola, NY 11501 Phone: 516-663-9500 Fax: 516-663-4613 | |
Dr. Anupama Ananda, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 190 Willis Ave, Suite 210, Mineola, NY 11501 Phone: 516-739-7290 Fax: 516-793-7291 | |
Mr. Jeffrey Liu, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 297 Mineola Blvd, Mineola, NY 11501 Phone: 516-294-1377 Fax: 516-294-5574 | |
Dr. Jonathan Shulman, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-2381 | |
John I Hogan, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 222 Station Plz N Ste 432, Mineola, NY 11501 Phone: 516-663-2507 | |
Dr. Anthony Massimillo, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 300 Old Country Rd Ste 31, Mineola, NY 11501 Phone: 516-294-9380 Fax: 516-294-5351 |